The balance sheet is heavily weighted toward intangible assets, with goodwill comprising $69.8 million of the $173.3 million total asset base as of 2026Q1.
| Total Current Assets | 45.9M | 71.89M | 344K | 528K | 1.13M | 13.89M | 29.34M |
| Cash & Short-Term Investments | - | - | - | - | - | - | - |
| Cash Only | - | - | - | - | - | - | - |
| Short-Term Investments | - | - | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - | - | - |
| Days Sales Outstanding | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 15.28M | 41.87M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 127.41M | 115.65M | 498K | 1.27M | 2.98M | 1.63M | 1.05M |
| Property, Plant & Equipment | 12K | 25K | 185K | 938K | 1.49M | 1.26M | 595K |
| Fixed Asset Turnover | 0.00x | - | 0.22x | 0.02x | 0.19x | 0.35x | - |
| Goodwill | 69.76M | 70.98M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 42.42M | 44.64M | 270K | 289K | 308K | 327K | 347K |
| Long-Term Investments | 142K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | - | - | - | - | - | - | - |
| Total Assets | 173.32M | 187.54M | 842K | 1.8M | 4.11M | 15.52M | 30.39M |
| Asset Turnover | 0.00x | - | 0.05x | 0.01x | 0.07x | 0.03x | - |
| Asset Growth % | 29427.9% | 22173.52% | -53.17% | -56.25% | -73.52% | -48.93% | - |
| Total Current Liabilities | 3.3M | 42.79M | 2.26M | 4.58M | 3.26M | 2.58M | 5.11M |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 38.02M | 0 | 0 | 0 | 0 | 313K |
| Deferred Revenue (Current) | 0 | - | - | - | - | - | - |
| Other Current Liabilities | 3.3M | 4.77M | 0 | 0 | 0 | 0 | 3.86M |
| Current Ratio | 13.90x | 1.68x | 0.15x | 0.12x | 0.35x | 5.39x | 5.74x |
| Quick Ratio | 13.90x | 1.68x | 0.15x | 0.12x | 0.35x | 5.39x | 5.74x |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 10.67M | 11.42M | 0 | 103K | 452K | 378K | 1K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | - | - | - | - | - | - |
| Deferred Tax Liabilities | 0 | - | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - | - | - |
| Total Liabilities | 13.97M | 54.22M | 2.26M | 4.68M | 3.71M | 2.95M | 5.11M |
| Total Debt | 0 | 38.02M | 102K | 452K | 765K | 656K | 314K |
| Net Debt | -6.86M | 17.7M | -40K | 262K | 408K | -11M | -27.95M |
| Debt / Equity | 0.00x | 0.29x | - | - | 1.93x | 0.05x | 0.01x |
| Debt / EBITDA | -0.00x | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.07x | - | - | - | - | - | - |
| Interest Coverage | 41.53x | -290.47x | -1146.27x | - | - | - | - |
| Total Equity | 159.24M | 133.22M | -1.42M | -2.89M | 397K | 12.56M | 25.28M |
| Equity Growth % | 12083.41% | 9468.71% | 50.74% | -827.2% | -96.84% | -50.29% | - |
| Book Value per Share | 3.32 | 2.78 | -0.10 | -0.39 | 0.09 | 3.75 | 9.06 |
| Total Shareholders' Equity | 158.99M | 133.19M | -1.44M | -2.91M | 418K | 12.35M | 24.48M |
| Common Stock | 98K | 50K | 17K | 9K | 5K | 36K | 31K |
| Retained Earnings | -764.81M | -718.12M | -255.34M | -245.01M | -215.97M | -188.92M | -157M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.1M | 814K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 256K | 32K | 17K | 26K | -21K | 219K | 802K |
Speculative pivot execution risk
As reported in recent SEC filings, STEX's total assets surged to $173.3 million in 2026Q1 from $0.84 million in 2024Q4, reflecting a massive structural shift following the merger that effectively replaced legacy medical technology assets with speculative fintech infrastructure and significant goodwill balances.
The rapid expansion of the asset base appears driven by inorganic growth rather than organic accumulation, suggesting the company is attempting to buy its way into the RWA tokenization market. Investors should monitor whether this asset inflation translates into operational utility or if it represents a temporary accounting artifact of the recent business combination.
Based on the company's latest financial statements, goodwill accounts for $69.8 million of the $173.3 million total asset base, indicating that a substantial portion of the firm's valuation is tied to intangible acquisition premiums rather than tangible, revenue-generating infrastructure or liquid capital reserves.
The heavy reliance on goodwill suggests that the company's book value is highly sensitive to impairment risks if the Streamex Exchange fails to achieve projected institutional adoption. This asset mix highlights a business model that is currently more dependent on acquisition-based accounting than on the underlying quality of its physical or digital assets.
According to the 2026Q1 balance sheet, STEX maintains $30.6 million in cash, which, when viewed against the company's aggressive acquisition and operational spending, suggests a limited buffer that warrants close monitoring as the firm attempts to scale its unproven gold-denominated treasury platform.
While the current ratio of 13.90 appears superficially strong, it is heavily distorted by the recent merger and does not necessarily reflect sustainable liquidity for ongoing operations. The rapid depletion of cash reserves in previous quarters implies that the current balance may be insufficient to support long-term development without further dilutive financing.
As indicated by historical financial data, the company's retained earnings have plummeted to a deficit of $764.8 million, a figure that underscores the severe value destruction associated with the legacy BioSig entity prior to the current pivot into the digital asset management sector.
This massive accumulated deficit suggests that the current equity position is largely supported by recent capital injections rather than historical profitability. Investors should be wary that the equity base may remain fragile as long as the company continues to report significant net losses and relies on stock-based compensation to manage its cost structure.
Quick answers to the most common questions about buying STEX stock.
As of 2025, Streamex Corp. (STEX) had total assets of $187.5M including $71.9M in current assets.
Streamex Corp. (STEX) carries total debt of $38.0M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Streamex Corp. (STEX) has total shareholders' equity (book value) of $133.2M ($2.78 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Streamex Corp. (STEX) reported a current ratio of 1.68x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.